Moreover, neuronal CD47 overexpression reduces microglial engulfment of synapses and overall synaptic loss caused by Aβ and plaque pathology, indicating that CD47 mediated pruning inhibition is a therapeutic target for AD. This evidence concerns the gene CD47 and Alzheimer disease.